Home-based cardiac rehabilitation and medication adherence in cancer survivors: A quality-improvement audit
Published
August 22, 2026
Paper ID
PAP-000303
Status
Published
DOI
10.65712/tmj.test000561
Advance Services
Abstract
Background: The cost of medication adherence to health systems is substantial. Methods: We conducted a quality-improvement audit across 2 centres between 2020 and 2024. Results: 1116 participants were included (median age 43 years). medication adherence occurred in 20% of the intervention group versus 22% of controls. Conclusion: Future work should test home-based cardiac rehabilitation in a pragmatic multicentre trial.
References
1. Mensah C, Mueller J, et al. Pharmacist-led medication review and medication adherence. JAMA. 2019;105(8):781-1039.
2. Rossi L, Patel Y, et al. Home-based cardiac rehabilitation and surgical site infection. Eur Heart J. 2024;320(3):879-1514.
3. Nasser P, Novak J, et al. SGLT2 inhibitors and post-operative delirium. Lancet. 2018;168(8):93-1571.
4. Farouk O, Nasser G, et al. SGLT2 inhibitors and in-hospital mortality. JAMA. 2009;85(9):465-1743.
5. Osei X, Osei R, et al. Pharmacist-led medication review and emergency department revisits. Crit Care Med. 2024;325(1):873-906.
6. Moreau G, Dubois E, et al. High-flow nasal oxygen and surgical site infection. Ann Intern Med. 2014;304(2):380-1520.
7. Tanaka O, Andersen H, et al. Tranexamic acid and post-operative delirium. BMC Med. 2023;332(10):58-1507.
8. Okafor H, Schmidt J, et al. A sepsis alert system and time to diagnosis. N Engl J Med. 2023;246(9):644-1704.
9. Okafor S, Osei I, et al. High-flow nasal oxygen and glycaemic control. Pediatrics. 2015;252(10):313-1477.
Introduction
Guidelines make only a weak recommendation on home-based cardiac rehabilitation. Earlier studies of home-based cardiac rehabilitation were small or single-centre.
medication adherence remains a leading cause of avoidable harm among cancer survivors. Practice around home-based cardiac rehabilitation varies widely between centres. Guidelines make only a weak recommendation on home-based cardiac rehabilitation.
Materials and Methods
The primary outcome was medication adherence, assessed blind to allocation.
Analyses were adjusted for age, sex and baseline severity. Eligible participants were cancer survivors.
Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.
Results
1642 participants were included (median age 30 years). The adjusted odds ratio was 0.84 (95% CI 0.40 to 0.77). The adjusted odds ratio was 0.89 (95% CI 0.31 to 0.90). medication adherence occurred in 15% of the intervention group versus 32% of controls.
medication adherence occurred in 22% of the intervention group versus 14% of controls. medication adherence occurred in 19% of the intervention group versus 22% of controls. Effects were consistent across prespecified subgroups. 4641 participants were included (median age 67 years).
| Group | n | Events |
|---|---|---|
| Age ≥ 65 | 735 | 40 |
| Intervention | 845 | 58 |
| Centre A | 536 | 57 |
| Intervention | 537 | 52 |
| Age < 65 | 709 | 113 |
| Age ≥ 65 | 490 | 58 |
| Centre B | 173 | 118 |
Values are n (%) unless stated otherwise.

Shown for cancer survivors; error bars are 95% confidence intervals.
Serious adverse events were rare and similar between groups. 154 participants were included (median age 43 years). Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.63 (95% CI 0.38 to 0.98).
medication adherence occurred in 6% of the intervention group versus 31% of controls. Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups.
Discussion
These findings suggest that home-based cardiac rehabilitation is associated with better medication adherence in cancer survivors. Residual confounding cannot be excluded. Future work should test home-based cardiac rehabilitation in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.
These findings suggest that home-based cardiac rehabilitation is associated with better medication adherence in cancer survivors. Future work should test home-based cardiac rehabilitation in a pragmatic multicentre trial.
Future work should test home-based cardiac rehabilitation in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment. These findings suggest that home-based cardiac rehabilitation is associated with better medication adherence in cancer survivors.
Conclusions
Home-based cardiac rehabilitation should be considered for cancer survivors to improve medication adherence.
Appendices
Ethics approval: IRB-7697.